BCYC
Bicycle Therapeutics Ltd
3.70$
+0.8%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +525.3% | +10.3% | +35.0% | +46.2% | +197.7% | -14.4% | +45.0% | +60.7% | -25.0% | |
| – | +533.6% | +7.4% | +35.7% | +49.5% | +194.5% | -19.4% | +52.1% | +65.3% | -26.5% | |
| – | +619.7% | -6.3% | +45.3% | +47.6% | +222.6% | -22.7% | +55.2% | +67.1% | -28.6% | |
| – | +619.7% | -6.3% | +45.3% | +47.6% | +222.6% | -22.7% | +55.2% | +67.1% | -28.6% | |
| – | +118.7% | +277.0% | -36.8% | +104.8% | -18.6% | +78.1% | +13.4% | +48.3% | -0.2% | |
| – | -100.0% | – | – | – | – | – | – | – | – | |
| – | +162.4% | +33.5% | +139.2% | -17.0% | +393.2% | +84.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +3,079.9% | +25.0% | -88.8% | +286.5% | +103.3% | +4.7% | +60.5% | -27.0% | -34.3% | |
| – | +148.0% | -5.5% | -1.2% | +162.2% | +56.7% | +47.2% | +30.4% | -3.3% | -15.2% | |
| – | – | -99.5% | +4,166.7% | +31.9% | +182.3% | +31.1% | +56.0% | +12.9% | -49.9% | |
| – | +9.6% | -8.6% | +3.3% | -30.0% | +99.3% | +137.9% | +101.6% | +21.0% | -38.8% | |
| – | – | – | – | – | +105.9% | +1.5% | +1.3% | – | – | |
| – | -688.0% | – | – | +2.4% | +262.7% | -21.8% | +37.0% | +113.8% | -23.1% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -24.9% | +0.0% | -16.9% | +73.3% | +30.9% | +18.4% | +20.0% | +63.5% | +19.0% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.